Circulation, Vol 74, 805-814, Copyright © 1986 by American Heart Association
JB Meddings and JM Dietschy
At the present time the most useful technique with which to examine the
kinetics of low-density lipoprotein (LDL) cholesterol in vivo is the
labeled LDL turnover study. However, a major limitation of this method is
that, despite its ability to accurately measure both the plasma LDL
concentration and LDL production rate, it cannot directly quantify LDL
receptor activity. The present study defines the equations that describe
the relationship between LDL cholesterol production rate, LDL receptor
number, and plasma LDL cholesterol concentration. These equations provide a
method that allows calculation of total LDL receptor activity based on the
results of an LDL turnover study. With the use of this technique and data
from previously published series, the effects of the genetic absence of
receptors, aging, and the treatment of hypercholesterolemia with mevinolin
on LDL cholesterol kinetics were analyzed.
ARTICLES
Regulation of plasma levels of low-density lipoprotein cholesterol: interpretation of data on low-density lipoprotein turnover in man
This article has been cited by other articles:
![]() |
E. R. Christ, M. H. Cummings, N. Jackson, M. Stolinski, P. J. Lumb, A. S. Wierzbicki, P. H. Sonksen, D. L. Russell-Jones, and A. M. Umpleby Effects of Growth Hormone (GH) Replacement Therapy on Low-Density Lipoprotein Apolipoprotein B100 Kinetics in Adult Patients with GH Deficiency: A Stable Isotope Study J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1801 - 1807. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Xie, L. A. Woollett, S. D. Turley, and J. M. Dietschy Fatty acids differentially regulate hepatic cholesteryl ester formation and incorporation into lipoproteins in the liver of the mouse J. Lipid Res., September 1, 2002; 43(9): 1508 - 1519. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Schaefer, S. Lamon-Fava, J. L. Jenner, J. R. McNamara, J. M. Ordovas, C. E. Davis, J. M. Abolafia, K. Lippel, and R. I. Levy Lipoprotein(a) Levels and Risk of Coronary Heart Disease in Men: The Lipid Research Clinics Coronary Primary Prevention Trial JAMA, April 6, 1994; 271(13): 999 - 1003. [Abstract] [PDF] |
||||
![]() |
M. J. MALLOY, J. P. KANE, S. T. KUNITAKE, and P. TUN Complementarity of Colestipol, Niacin, and Lovastatin in Treatment of Severe Familial Hypercholesterolemia Ann Intern Med, November 1, 1987; 107(5): 616 - 623. [Abstract] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1986 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |